Immuno-histochemical Expression of Cyclin D1 in Oral Squamous Cell Carcinoma, Oral Potentially Malignant Disorders, and Normal Oral Mucosa-Reference-Cited by-同舟云学术

Immuno-histochemical Expression of Cyclin D1 in Oral Squamous Cell Carcinoma, Oral Potentially Malignant Disorders, and Normal Oral Mucosa

Published:2022-07-31 Issue: Volume: Page:178-182
ISSN:2709-2798
Container-title:Pakistan BioMedical Journal
language:
Short-container-title:PBMJ

Author:

Bakhtiar Shabana,Nasir Sabeen,Zia Sara,Maryam Hoor,Kamran Natasha,Ali Karishma

Abstract

Due to a high risk and tendency of OPMDs towards OSCC, its early detection is essential for better survival rate. Several molecular markers are available for diagnosis and prognostic assessments of OPMDs, also evaluating aggressiveness of OSCC. Objectives: To assess the immuno-histochemical expression of Cyclin D1 in OSCC, OPMDs, and normal healthy oral mucosa. Cyclin D1 has a significant role in cell cycle control and also strongly linked with the metastatic and poorly differentiated tumour cells. Methods: The study comprised of already diagnosed 20 cases of OSCC, 20 cases of OPMDs, and 20 normal oral mucosa cells, as a control. Results: Cyclin D1 immuno-reactivity was found positive in 100% cases of OPMDs, and 100% in OSCC but not in normal oral mucosa cells. Conclusion: A statistically significant expression of Cyclin D1 was observed in OPMDs which may indicate the probability of their transformation to OSCC.

Publisher

CrossLinks International Publishers

Subject

General Engineering

Reference29 articles.

1. 1. Miranda-Filho A, Bray F. Global patterns and trends in cancers of the lip, tongue and mouth. Oral Oncology. 2020 Mar; 102:104551. doi: 10.1016/j.oraloncology.2019.104551.

2. 2. Dourado MR, de Oliveira CE, Sawazaki-Calone I, Sundquist E, Coletta RD, Salo T. Clinicopathologic significance of ROCK2 expression in oral squamous cell carcinomas. Journal of Oral Pathology and Medicine. 2018 Feb; 47(2):121-127. doi: 10.1111/jop.12651.

3. 3. Song X, Yang X, Narayanan R, Shankar V, Ethiraj S, Wang X, et al. Oral squamous cell carcinoma diagnosed from saliva metabolic profiling. Proceedings of National Academy of Sciences U S A. 2020 Jul; 117(28):16167-16173. doi: 10.1073/pnas.2001395117.

4. 4. Adjei Boakye E, Buchanan P, Hinyard L, Osazuwa-Peters N, Schootman M, Piccirillo JF. Incidence and Risk of Second Primary Malignant Neoplasm After a First Head and Neck Squamous Cell Carcinoma. JAMA Otolaryngology; Head and Neck Surgery. 2018 Aug; 144(8):727-737. doi: 10.1001/jamaoto.2018.0993.

5. 5. Anwar N, Pervez S, Chundriger Q, Awan S, Moatter T, Ali TS. Oral cancer: Clinicopathological features and associated risk factors in a high risk population presenting to a major tertiary care center in Pakistan. PLoS One. 2020 Aug; 15(8):e0236359. doi: 10.1371/journal.pone.0236359.